✦ LIBER ✦

Phase i/ii study of docetaxel (DOC) and carboplatin (CBDCA) with concurrent radiotherapy in patients with stage III unresectable non-small cell lung cancer (NSCLC), preliminary results

✍ Scribed by S. Kato; M. Sakura; T. Kazumoto; H. Sakai; S. Yoneda; Y. Noguchi; K. Kobayashi; S. Honda; S. Kosaihira

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of weekly docetaxel (DTX)

✍ Murakami, H; Kubota, K; Ohe, Y; Watanabe, H; Sawada, M; Akiyama, Y; Kusaba, H; Y 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB

A phase I study of carboplatin (Car) and

✍ Skarin, A.T; Lynch, C.M; Lucca, J; Boral, A.L; Lynch, T.J; Herbst, R.S; Berman, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB

A phase I study of irinotecan and carbop

✍ T. Kurata; M. Yamada; S. Kudoh; N. Yamamoto; K. Nakagawa; K. Takeda; S. Negoro; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 177 KB

Concomitant chemoradiotherapy using peme

✍ Xu, Yaping; Ma, Shenglin; Ji, Yongling; Sun, Xiaojiang; Jiang, Hao; Chen, Jianxi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Phase I study of weekly docetaxel and ci

✍ Hong-Gyun Wu; Yung-Jue Bang; Eun Kyung Choi; Yong Chan Ahn; Young Whan Kim; Tae- 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Phase II study of bi-weekly docetaxel an

✍ Sakai, H 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 93 KB